Anthropic just bought a one-person drug company
Plus: Automated labs built in America, a $600 million drug-development fund, and the argument over whether AI needs to simulate biology to cure disease.
BAIO
AI and biotechnology briefing covering research, deals, tools and scientific industry news.
By BAIO
Latest issues
The 6 things BAIO actually covers
💡Pro tip: To make sure BAIO lands in your inbox (not spam), drag this email to your Primary tab or add [email protected] to your contacts.
Welcome to BAIO 🧬
AI is rewriting biology - and the field is moving faster than anyone can track. That’s the problem BAIO solves.